Medicare Enrolled
Dr. Ana Van Der Wall, MD
Hematology · Bradenton, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Van Der Wall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Van Der Wall?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Van Der Wall
Dr. Ana Van Der Wall is a hematology specialist in Bradenton, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Van Der Wall performed 264,925 Medicare services across 4,183 unique beneficiaries.
Between the years covered by Open Payments, Dr. Van Der Wall received a total of $6,587 from 69 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Van Der Wall is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 10% volume in FL
$6,587 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 121065 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗264,925
Medicare services
Top 10% in FL for hematology
4,183
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15,584 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
64,260 | $0 | $4 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
62,250 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 28,200 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 20,880 | $18 | $51 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
18,120 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 15,340 | $1 | $5 |
| Paclitaxel chemotherapy injection | 13,681 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
12,630 | $6 | $23 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
5,925 | $34 | $140 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
3,960 | $26 | $116 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,927 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,766 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,730 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,050 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,175 | $97 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
957 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 912 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
777 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
633 | $96 | $378 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
611 | $63 | $239 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
462 | $47 | $189 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
318 | $10 | $42 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
294 | $22 | $84 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
272 | $3 | $11 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
227 | $2 | $7 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
225 | $136 | $474 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
224 | $2 | $13 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
205 | $1 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
198 | $1 | $6 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
189 | $2 | $41 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
153 | $6 | $69 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
150 | $21 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
138 | $49 | $178 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
115 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 111 | $162 | $585 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
109 | $25 | $89 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
108 | $1 | $2 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
106 | $16 | $59 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
93 | $23 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
91 | $15 | $56 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
82 | $42 | $170 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
72 | $28 | $156 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 69 | $135 | $562 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
35 | $52 | $206 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
28 | $5 | $20 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
25 | $4 | $10 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $91 | $285 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $79 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.7% high complexity
46.1% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,587
Total received (2018-2024)
Avg $941/year across 7 years
Bottom 46% in FL for hematology
69
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,587 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,308
2023
$1,206
2022
$820
2021
$1,479
2020
$916
2019
$453
2018
$406
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$812
Celgene Corporation
$447
PFIZER INC.
$348
Novartis Pharmaceuticals Corporation
$321
AstraZeneca Pharmaceuticals LP
$299
Janssen Biotech, Inc.
$280
Daiichi Sankyo Inc.
$275
Gilead Sciences, Inc.
$257
GENZYME CORPORATION
$252
Merck Sharp & Dohme LLC
$251
Astellas Pharma US Inc
$237
Amgen Inc.
$205
Kite Pharma, Inc.
$203
BeiGene USA, Inc.
$147
Genentech USA, Inc.
$128
Incyte Corporation
$126
Seagen Inc.
$119
ARRAY BIOPHARMA INC
$104
Rigel Pharmaceuticals, Inc.
$102
Merck Sharp & Dohme Corporation
$98
Takeda Pharmaceuticals U.S.A., Inc.
$92
Epizyme, Inc.,
$84
Lilly USA, LLC
$83
Pharmacyclics LLC, An AbbVie Company
$81
PUMA BIOTECHNOLOGY, INC.
$75
Dendreon Pharmaceuticals LLC
$65
ABBVIE INC.
$59
Dova Pharmaceuticals
$59
Stemline Therapeutics Inc.
$46
Eisai Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$43
Karyopharm Therapeutics Inc.
$40
Myovant Sciences Inc.
$40
AbbVie Inc.
$38
GlaxoSmithKline, LLC.
$38
Servier Pharmaceuticals LLC
$37
SpringWorks Therapeutics, Inc.
$36
Taiho Oncology, Inc.
$36
Sobi, Inc
$33
Heron Therapeutics, Inc.
$30
PharmaEssentia USA Corporation
$30
Myriad Genetic Laboratories, Inc.
$29
Jazz Pharmaceuticals Inc.
$26
TerSera Therapeutics LLC
$25
Regeneron Healthcare Solutions, Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
Pharmacyclics LLC, an AbbVie Company
$24
Deciphera Pharmaceuticals Inc.
$22
AbbVie, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$20
ADC Therapeutics America, Inc.
$20
Alnylam Pharmaceuticals Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Mirati Therapeutics, Inc.
$18
Blueprint Medicines Corporation
$18
TG Therapeutics, Inc.
$18
Epizyme, Inc.
$17
Sirtex Medical Inc
$17
Sumitomo Pharma America, Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
Exelixis Inc.
$13
Acceleron Pharma, Inc.
$13
SERVIER PHARMACEUTICALS LLC
$13
NanoString Technologies, Inc.
$12
Acrotech Biopharma LLC
$12
Teva Pharmaceuticals USA, Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Aurobindo Pharma USA, Inc.
$11
Veracyte, Inc.
$0
Top 3 companies account for 24.4% of total payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BRAFTOVI · BRUKINSA · CALQUENCE · CERDELGA · CEREZYME · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FERAHEME · FRUZAQLA · GAZYVA · GIVLAARI · HEMADY · IBRANCE · IMBRUVICA · INREBIC · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · ONCASPAR · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PLUVICTO · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Reblozyl · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Sustol · TAGRISSO · TASIGNA · TAZVERIK · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zevalin · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
19
Per 100K population
4.6
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Van Der Wall is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Van Der Wall experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Van Der Wall performed 64,260 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Van Der Wall receive payments from pharmaceutical companies?
Yes. Dr. Van Der Wall received a total of $6,587 from 69 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Van Der Wall's costs compare to other hematologists in Bradenton?
Dr. Van Der Wall's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Van Der Wall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Bradenton
Browse hematologists in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology